Accelerating Pneumococcal Conjugate Vaccine introductions in Indonesia: key learnings from 2017 to 2022

Despite high pneumococcal disease and economic burden in Indonesia and interest to introduce pneumococcal conjugate vaccine (PCV), there were challenges in establishing a comprehensive strategy to accelerate and enable the introduction in country in the early 2010s. Starting in 2017, Clinton Health...

Descripción completa

Detalles Bibliográficos
Autores principales: Athiyaman, Anithasree, Herliana, Putri, Anartati, Atiek, Widyastuti, Niken, Yosephine, Prima, Tandy, Gertrudis, Karolina, Sherli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683141/
https://www.ncbi.nlm.nih.gov/pubmed/38017524
http://dx.doi.org/10.1186/s40249-023-01161-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683141/
https://www.ncbi.nlm.nih.gov/pubmed/38017524
http://dx.doi.org/10.1186/s40249-023-01161-5

Ejemplares similares